Glen Eagle Advisors, LLC Clear Point Neuro, Inc. Transaction History
Glen Eagle Advisors, LLC
- $593 Billion
- Q3 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 50 shares of CLPT stock, worth $785. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$785
Previous $270,000
107.78%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.81MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$19.5 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$7.29 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$5.89 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.76 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.24 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $385M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...